Growth Equity Opportunities 17, LLC - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2025-11-14
4:27 pm
Unchanged		2025-11-1213DSAVARA INC
SVRA		Growth Equity Opportunities 17, LLC24,471,264
12.000%		0
(Unchanged)		Filing
History
2024-08-14
8:45 pm
Unchanged		2024-08-1213DSAVARA INC
SVRA		Growth Equity Opportunities 17, LLC24,471,264
14.900%		0
(Unchanged)		Filing
History
2023-07-26
4:57 pm
Purchase		2023-07-1713DSAVARA INC
SVRA		Growth Equity Opportunities 17, LLC24,471,264
18.100%		333,333increase
(+1.38%)		Filing
History
2023-05-02
5:26 pm
Sale		2023-04-1813DSATSUMA PHARMACEUTICALS INC CO
STSA		Growth Equity Opportunities 17, LLC0
0.000%		-2,488,587decrease
(Position Closed)		Filing
History
2023-02-03
5:27 pm
Sale		2023-01-2713DGERON CORP
GERN		Growth Equity Opportunities 17, LLC0
0.000%		-20,192,307decrease
(Position Closed)		Filing
History
2023-01-27
4:58 pm
Sale		2023-01-2013DSATSUMA PHARMACEUTICALS INC CO
STSA		Growth Equity Opportunities 17, LLC2,488,587
7.500%		-504,371decrease
(-16.85%)		Filing
History
2022-08-12
5:15 pm
Sale		2022-07-2213DVISTAGEN THERAPEUTICS, INC. CO
VTGN		Growth Equity Opportunities 17, LLC0
0.000%		-543,420decrease
(Position Closed)		Filing
History
2021-04-29
10:17 am
Purchase		2021-03-2613DVISTAGEN THERAPEUTICS, INC. CO
VTGN		Growth Equity Opportunities 17, LLC543,420
8.600%		231,420increase
(+74.17%)		Filing
History